Merck collaborates with Stelis Biopharma to open joint Process Scale-Up Lab in India

Merck announced its collaboration with Stelis Biopharma to open its first joint Process Scale-Up Lab at the Stelis Biopharma R&D Facility in the Jigani industrial estate, Bangalore.

The lab is a center of excellence for process scale-up and manufacturing services. The collaboration brings together Stelis’ end-to-end capabilities in high-yield bio process development from cell line to commercial manufacturing scale and Merck’s industry leading technological expertise in bio processing.

Stelis Biopharma CEO Joe Thomas said that in the biopharma space, where the process is the product, their Process Scale-Up Lab fulfils a critical need by offering clients a reliable process bridge between R&D and commercial scales. The collaboration with Merck completes the value proposition for CDMO customers by providing an end-to-end solution from process development and scale-up through to manufacturing for pre-clinical, clinical and commercial supply.

The Process Scale-Up Lab and a soon-to-be-completed cGMP manufacturing facility will house Merck’s portfolio of Mobius bio processing equipment and single-use manufacturing components. Merck will provide process know-how and application knowledge to help establish the single-use platform technologies at Stelis as part of the collaboration.